Literature DB >> 10922472

In vivo localisation and stability of human Mcl-1 using green fluorescent protein (GFP) fusion proteins.

C Akgul1, D A Moulding, M R White, S W Edwards.   

Abstract

Mcl-1 is an anti-apoptotic member of the Bcl-2 family of proteins. We have expressed full length and mutated GFP:Mcl-1 fusion proteins to define structural motifs that control protein localisation and stability. When expressed in U-937 cells, full length Mcl-1 locates primarily within mitochondria and its half-life was approximately 3 h, which was identical to the native, endogenously expressed protein. When the terminal 20 amino acids from the C-terminus of the protein were detected, the protein was diffused in the cytoplasm, but its stability was unaffected. This confirms that this region is responsible for efficient targeting to mitochondria. Surprisingly, deletion of 104 amino acids (residues 79-183) that contain putative PEST sequences and other stability regulating motifs, did not affect protein stability.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10922472     DOI: 10.1016/s0014-5793(00)01809-3

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  33 in total

Review 1.  Neutrophil apoptosis: relevance to the innate immune response and inflammatory disease.

Authors:  Sarah Fox; Andrew E Leitch; Rodger Duffin; Christopher Haslett; Adriano G Rossi
Journal:  J Innate Immun       Date:  2010-02-11       Impact factor: 7.349

2.  Akt3-mediated resistance to apoptosis in B-RAF-targeted melanoma cells.

Authors:  Yongping Shao; Andrew E Aplin
Journal:  Cancer Res       Date:  2010-07-20       Impact factor: 12.701

3.  Staurosporine resistance in inflammatory neutrophils is associated with the inhibition of caspase- and proteasome-mediated Mcl-1 degradation.

Authors:  Tamara Hornstein; Sarah Lehmann; Denise Philipp; Susanne Detmer; Michèle Hoffmann; Christoph Peter; Sebastian Wesselborg; Klaus Unfried; Joachim Windolf; Sascha Flohé; Adnana Paunel-Görgülü
Journal:  J Leukoc Biol       Date:  2015-08-26       Impact factor: 4.962

Review 4.  Bodyguards and assassins: Bcl-2 family proteins and apoptosis control in chronic lymphocytic leukaemia.

Authors:  Graham Packham; Freda K Stevenson
Journal:  Immunology       Date:  2005-04       Impact factor: 7.397

Review 5.  Enzymatic labeling of proteins: techniques and approaches.

Authors:  Mohammad Rashidian; Jonathan K Dozier; Mark D Distefano
Journal:  Bioconjug Chem       Date:  2013-08-21       Impact factor: 4.774

6.  Acquired resistance to ABT-737 in lymphoma cells that up-regulate MCL-1 and BFL-1.

Authors:  Derek Yecies; Nicole E Carlson; Jing Deng; Anthony Letai
Journal:  Blood       Date:  2010-03-02       Impact factor: 22.113

7.  Anti-apoptotic proteins BCL-2, MCL-1 and A1 summate collectively to maintain survival of immune cell populations both in vitro and in vivo.

Authors:  Emma M Carrington; Yifan Zhan; Jamie L Brady; Jian-Guo Zhang; Robyn M Sutherland; Natasha S Anstee; Robyn L Schenk; Ingela B Vikstrom; Rebecca B Delconte; David Segal; Nicholas D Huntington; Philippe Bouillet; David M Tarlinton; David Cs Huang; Andreas Strasser; Suzanne Cory; Marco J Herold; Andrew M Lew
Journal:  Cell Death Differ       Date:  2017-03-31       Impact factor: 15.828

8.  The stress protein BAG3 stabilizes Mcl-1 protein and promotes survival of cancer cells and resistance to antagonist ABT-737.

Authors:  Mariana Boiani; Cristina Daniel; Xueyuan Liu; Michael D Hogarty; Lawrence J Marnett
Journal:  J Biol Chem       Date:  2013-01-22       Impact factor: 5.157

9.  Ubiquitin-independent degradation of antiapoptotic MCL-1.

Authors:  Daniel P Stewart; Brian Koss; Madhavi Bathina; Rhonda M Perciavalle; Kristen Bisanz; Joseph T Opferman
Journal:  Mol Cell Biol       Date:  2010-04-12       Impact factor: 4.272

10.  Human Cytomegalovirus Stimulates the Synthesis of Select Akt-Dependent Antiapoptotic Proteins during Viral Entry To Promote Survival of Infected Monocytes.

Authors:  Megan A Peppenelli; Kyle C Arend; Olesea Cojohari; Nathaniel J Moorman; Gary C Chan
Journal:  J Virol       Date:  2016-01-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.